ICD10 code of Spinal Muscular Atrophy and ICD9 code

The primary ICD-10-CM code for Spinal Muscular Atrophy (SMA) is G12.0 (Infantile spinal muscular atrophy, type I, Werdnig-Hoffman), while other forms are classified under G12.1 (Other inherited spinal muscular atrophy). In the older ICD-9-CM classification system, Spinal Muscular Atrophy was historically coded as 335.0 (Werdnig-Hoffman disease) or 335.1 (Other spinal muscular atrophy).

Why are medical coding systems like ICD-10 important for Spinal Muscular Atrophy?

Accurate medical coding is essential for patients living with Spinal Muscular Atrophy because these codes facilitate insurance reimbursement, hospital administration, and public health tracking. Because Spinal Muscular Atrophy is a progressive neurodegenerative condition, precise coding ensures that specialists—such as neurologists and pulmonologists—can effectively manage the long-term care plans required by patients. For the 972 members of the Spinal Muscular Atrophy community on DiseaseMaps.org, understanding these codes can be helpful when navigating complex healthcare systems or advocating for specialized therapies.

How is Spinal Muscular Atrophy classified clinically?

While ICD-10 codes provide administrative categorization, clinicians classify Spinal Muscular Atrophy based on the age of onset and the highest motor milestone achieved. This genetic disorder is caused by a mutation in the SMN1 gene, leading to the loss of motor neurons in the spinal cord. Clinical classification typically follows this structure:

• Type 0: Prenatal onset, the most severe form with limited movement.


• Type 1 (Werdnig-Hoffman): Onset before 6 months; patients typically cannot sit independently.


• Type 2 (Dubowitz disease): Onset between 6-18 months; patients can sit but cannot walk independently.


• Type 3 (Kugelberg-Welander): Onset after 18 months; patients can walk independently but may lose this ability over time.


• Type 4: Adult-onset; typically presents with mild motor impairment in adulthood.

Is Spinal Muscular Atrophy hereditary and how is it diagnosed?

Spinal Muscular Atrophy is an autosomal recessive condition, meaning an individual must inherit two mutated copies of the SMN1 gene—one from each carrier parent—to be affected. Genetic testing is the gold standard for diagnosis, involving a blood test that detects the deletion or mutation of the SMN1 gene. Because Spinal Muscular Atrophy affects muscle tone and respiratory function, early diagnosis is critical for accessing life-altering disease-modifying therapies that have emerged in recent years.

Next steps

• Consult with a board-certified pediatric or adult neurologist specializing in neuromuscular disorders to confirm your specific genetic diagnosis.


• Request a copy of your genetic testing report to understand your specific SMN1 copy number, which is vital for treatment eligibility.


• Connect with the 972 other members on DiseaseMaps.org to share experiences regarding care coordination and accessing specialized treatments.


• Reach out to organizations like the SMA Foundation or Cure SMA for resources on clinical trials and patient support programs.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Spinal muscular atrophy (ORPHA:83395)


• NIH Genetic and Rare Diseases (GARD) Information Center: Spinal Muscular Atrophy


• OMIM (Online Mendelian Inheritance in Man): Spinal Muscular Atrophy, Type I (Entry #253300)


• Cure SMA: Understanding SMA Diagnosis and Standards of Care